An oasis in the desert of cancer chemotherapeutic resistance: The enlightenment from reciprocal crosstalk between signaling pathways of UPR and autophagy in cancers - 01/07/17
pages | 10 |
Iconographies | 3 |
Vidéos | 0 |
Autres | 0 |
Abstract |
Endoplasmic reticulum (ER), principal but complex, functions as the pleiotropic organelle for proper protein folding, Ca2+ storage as well as lipid and carbohydrate metabolisms. Diverse microenviromental insults including, but not limited to, inflammatory reaction, glucose imbalance and hypoxia, elicit the accumulation of potentially toxic unfolded proteins in the ER lumen. Under the condition of these cellular threats, the autophagy with the well-orchestrated program containing over 30 autophagy-related genes (ATGs) might be initiated for degrading and recycling of the cumulative misfolded proteins and other related abnormal cytoplasmic components. The link between UPR and autophagy has been verified as the PERK-eIF2α-ATF4 signaling pathway by ongoing research, and the transcription factor C/EBP homologous (CHOP) mediated by ATF4 were further substantiated to regulate a dozen of ATG genes transcriptionally. Recent researches showed that the crosstalk between these signaling systems might mainly account for chemotherapy resistance in many cancers because the chemoresistant phenotypes are usually concomitant with increasing autophagy when drugs were administrated to trigger inflammatory microenvironment and other dyshomeostasis. We summarized recent researches in the molecular link between UPR and autophagy signaling pathways as well as the perspectives of potential inhibitors targeting the Achilles heel for further clinical use.
Le texte complet de cet article est disponible en PDF.Keywords : Endoplasmic reticulum (ER), Unfolded protein response (UPR), Autophagy, The PERK-eIF2α-ATF4 pathway, C/EBP homologous (CHOP), Chemotherapeutic resistance
Plan
Vol 92
P. 972-981 - août 2017 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?